鼻咽癌
生发中心
CXCL13型
免疫疗法
等离子体电池
CD8型
细胞
B细胞
癌症研究
癌症免疫疗法
癌细胞
生物
医学
癌症
抗体
免疫学
放射治疗
免疫系统
内科学
遗传学
趋化因子
趋化因子受体
作者
Yang Liu,Shuangyan Ye,Shuai He,Dongmei Chi,Xiuzhi Wang,Yue‐Feng Wen,Dong Ma,Run‐Cong Nie,Xiang Pu,You Zhou,Zhao-Hui Ruan,Roujun Peng,Chun-Ling Luo,Panpan Wei,Guo‐Wang Lin,Jian Zheng,Qian Cui,Muyan Cai,Jing‐Ping Yun,Junchao Dong,Hai‐Qiang Mai,Xiaojun Xia,Jin‐Xin Bei
标识
DOI:10.1038/s41467-024-52153-4
摘要
Abstract Tertiary lymphoid structures are immune cell aggregates linked with cancer outcomes, but their interactions with tumour cell aggregates are unclear. Using nasopharyngeal carcinoma as a model, here we analyse single-cell transcriptomes of 343,829 cells from 77 biopsy and blood samples and spatially-resolved transcriptomes of 31,316 spots from 15 tumours to decipher their components and interactions with tumour cell aggregates. We identify essential cell populations in tertiary lymphoid structure, including CXCL13 + cancer-associated fibroblasts, stem-like CXCL13 + CD8 + T cells, and B and T follicular helper cells. Our study shows that germinal centre reaction matures plasma cells. These plasma cells intersperse with tumour cell aggregates, promoting apoptosis of EBV-related malignant cells and enhancing immunotherapy response. CXCL13 + cancer-associated fibroblasts promote B cell adhesion and antibody production, activating CXCL13 + CD8 + T cells that become exhausted in tumour cell aggregates. Tertiary lymphoid structure-related cell signatures correlate with prognosis and PD-1 blockade response, offering insights for therapeutic strategies in cancers.
科研通智能强力驱动
Strongly Powered by AbleSci AI